Recharge Reports Record 39% Sales Growth in 2024 and have made a Strategic Leap Into B2B
Total sales up 39% to €695 million Net revenue up 32% to €73.6 million EBITDA doubling to €8.1 million and net profit reaching €7.5 million Secured €45 million acquisition financing facility from ABN AMRO Entered 2025 with the acquisition of...
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December...